Matthew E Korenberg, EVP of Ligand Pharmaceuticals Incorporated, recently acquired 500 shares of the company. The buys took place at $86.18 per share, on September 03, 2019. Korenberg now owns 17,151 shares of the company. Korenberg operates out of San Diego, CA.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!